DE

The Future Map · technological enabler · active

Synthetic Biology

Maturity

2 / 5

Basis, source, vintage

Commercial in specific ingredients and materials; broader engineering of organisms remains research-stage. Design accelerating faster than scale-up.

Source: E-143 (NASEM, The Age of AI in the Life Sciences, 23 Apr 2025); WKO Innovation Map (2025–2026)

What it is

Designing and building biological systems that do not exist in nature — engineered organisms, synthetic chromosomes and designed proteins.

What it does

It treats biology as a manufacturing platform. Where it works, it substitutes biological production for chemical or extractive production, which changes supply chains rather than efficiency.

Common misconception

That it is an extension of gene editing. Editing modifies what exists; this builds what does not, and the design, biosecurity and scale-up questions are correspondingly different.

Steepens

A megatrend runs at the pace of its shallowest enabler. Marginal links are shown but never set the pace.

What would change its gradient

Shares megatrends with

In the book

Why the Future Arrives Unevenly — Ch. 9 — The Closing of the Planetary Envelope · Ch. 12 — Reading the Ramp · Ch. 14 — How Hype Is Manufactured

Sources


See it in the map →

Cite this entry

Talin, B. (2026). Synthetic Biology. The Future Map, dataset v0.4.0 (2026-09-07). https://futuremap.talin.digital/e/synthetic-biology/

Machine view: This entry as Markdown · The whole map as JSON

Updated 2026-09-02.